Cecropin B (CAS 80451-05-4)

Cecropin B is an antimicrobial peptide (AMP) derived from the hemolymph of the cecropia moth, exhibiting potent activity against a wide range of bacteria, including both Gram-positive and Gram-negative species. Its mechanism of action involves disrupting bacterial cell membranes, leading to increased membrane permeability and cell lysis. Cecropin B interacts with the lipid bilayer of bacterial membranes, inserting itself into the membrane and forming pores. This pore formation compromises the integrity of the bacterial cell membrane, causing leakage of cellular contents and ultimately cell death. In research, cecropin B is extensively studied for its role in innate immune defense and its antimicrobial properties. It is used as a model peptide to investigate the structure-activity relationships of AMPs, providing valuable insights into how specific amino acid sequences and peptide structures influence antimicrobial efficacy. Researchers employ cecropin B in studies aimed at understanding the dynamics of membrane disruption and the kinetics of bacterial killing, as well as exploring the peptide′s selectivity for bacterial cells over eukaryotic cells. Moreover, cecropin B is utilized in synthetic biology and bioengineering to design and develop novel antimicrobial peptides with enhanced stability and efficacy. Studies often focus on modifying the peptide to improve its resistance to proteolytic degradation and to enhance its antimicrobial activity. The fundamental research on cecropin B significantly contributes to the development of new antimicrobial agents and the understanding of host-pathogen interactions, providing a basis for future innovations in combating bacterial infections.